These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38635977)

  • 1. Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia.
    Garcia V; McCann L; Lauber E; Vaccaro C; Swauger M; Heckert DA
    Subst Use Misuse; 2024; 59(9):1313-1322. PubMed ID: 38635977
    [No Abstract]   [Full Text] [Related]  

  • 2. High-risk Individuals and Naloxone Use: Implications for THN Programs in Rural Appalachian Communities.
    Garcia V; McCann L; Lauber E; Vaccaro C; Swauger M; Heckert AD
    J Appalach Health; 2023; 5(3):9-21. PubMed ID: 38784143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
    Sajwani HS; Williams AV
    Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
    Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
    Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
    Sampson FC; Hughes J; Long J; Buykx P; Goodacre SW; Snooks H; Edwards A; Evans B; Jones J; Moore C; Johnston S
    BMC Emerg Med; 2024 Apr; 24(1):75. PubMed ID: 38679713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
    Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
    BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural Appalachia.
    Macmadu A; Gurka KK; Linn HI; Smith GS; Feinberg J
    Subst Use Misuse; 2023; 58(2):163-170. PubMed ID: 36546533
    [No Abstract]   [Full Text] [Related]  

  • 10. Efforts to Improve Naloxone Co-Prescription for Patients With Cancer Pain at Risk of Opioid Overdose.
    Amaram-Davila J; Reddy A; Arthur J; Narayanan S; Gogineni M; Mallipeddi T; De Moraes AR; Maddi R; Shelal Z; Urbauer D; Chen M; Bruera E
    J Palliat Med; 2023 Jul; 26(7):969-973. PubMed ID: 37074064
    [No Abstract]   [Full Text] [Related]  

  • 11. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.
    Bunting AM; Oser CB; Staton M; Eddens KS; Knudsen H
    Addict Sci Clin Pract; 2018 Dec; 13(1):23. PubMed ID: 30509314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
    Leiner C; Cody T; Mullins N; Ramage M; Ostrach BMM
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):143. PubMed ID: 33596843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing medical simulations for opioid overdose response training: A qualitative analysis of narratives from responders to overdoses.
    Edwards GF; Mierisch C; Mutcheson B; Strauss A; Coleman K; Horn K; Parker SH
    PLoS One; 2024; 19(3):e0294626. PubMed ID: 38547079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
    Neale J; Kalk NJ; Parkin S; Brown C; Brandt L; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
    J Subst Abuse Treat; 2020 Oct; 117():108099. PubMed ID: 32811629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
    Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
    Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdose responses among rural people who use drugs: A multi-regional qualitative study.
    Baker R; Fredericksen RJ; Rudolph AE; Stopka TJ; Walters SM; Fadanelli M; Bolinski RS; Sibley AL; Stack E; Crane HM; Korthuis PT; Seal DW
    Harm Reduct J; 2024 May; 21(1):107. PubMed ID: 38822387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.